This study investigates the causal relationship between gut microbiota and alopecia areata (AA) using data from GWAS involving 13,266 individuals for gut microbiota and 211,428 for AA. The analysis suggests that certain gut bacteria, such as Butyricimonas, Enterorhabdus, Eubacterium (xylanophilum group), and Phascolarctobacterium, may have a protective effect against AA, while Ruminococcaceae UCG003 may increase the risk. Reverse analysis showed no significant causal effect of AA on gut microbiota. The findings highlight the potential role of gut microbiota in the pathogenesis and treatment of AA.
1 citations,
April 2023 in “Frontiers in Immunology” New treatments for hair loss from alopecia areata may include targeting immune cells, using stem cells, balancing gut bacteria, applying fatty acids, and using JAK inhibitors.
66 citations,
October 2021 in “Journal of The American Academy of Dermatology” Baricitinib is effective and safe for treating severe alopecia areata.
July 2023 in “Research Square (Research Square)” This study investigates the causal relationship between gut microbiota and alopecia areata (AA) using data from GWAS involving 13,266 individuals for gut microbiota and 211,428 for AA. The analysis suggests that certain gut bacteria, such as Butyricimonas, Enterorhabdus, Eubacterium (xylanophilum group), and Phascolarctobacterium, may have a protective effect against AA, while Ruminococcaceae UCG003 may increase the risk. Reverse analysis showed no significant causal effect of AA on gut microbiota. The findings highlight the potential role of gut microbiota in the pathogenesis and treatment of AA.
